Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anthony Moody

Showing results (61-70 of 200) with videos related to

Pageof 20
Sort By:
The Journal of Infectious Diseases|December 28, 2021
Frequent Development of Broadly Neutralizing Antibodies in Early Life in a Large Cohort of Children With Human Immunodeficiency VirusAmanda Lucier, Youyi Fong, Shuk Hang Li, et al.
Frontiers in Immunology|April 24, 2023
H3N2 influenza hemagglutination inhibition method qualification with data driven statistical methods for human clinical trialsSheetal Sawant, Sarah Anne Gurley, R Glenn Overman, et al.
Journal of Virology|April 13, 2012
A novel variant marking HLA-DP expression levels predicts recovery from hepatitis B virus infectionRasmi Thomas, Chloe L Thio, Richard Apps, et al.
Pediatrics|March 28, 2022
Safety of Live Attenuated Influenza Vaccine in Children With AsthmaAndrew G Sokolow, Amy P Stallings, Carolyn Kercsmar, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 10, 2011
Broadly neutralizing human antibody that recognizes the receptor-binding pocket of influenza virus hemagglutininJames R R Whittle, Ruijun Zhang, Surender Khurana, et al.
Cell Reports|May 11, 2016
A Therapeutic Antibody for Cancer, Derived from Single Human B CellsRyan T Bushey, M Anthony Moody, Nathan L Nicely, et al.
Mbio|July 2, 2020
Recognition Patterns of the C1/C2 Epitopes Involved in Fc-Mediated Response in HIV-1 Natural Infection and the RV114 Vaccine TrialWilliam D Tolbert, Verna Van, Rebekah Sherburn, et al.
Emerging Microbes & Infections|October 29, 2024
Circulating HBsAg-specific B cells are partially rescued in chronically HBV-infected patients with functional cureShuqin Gu, Libo Tang, Ling Guo, et al.
Frontiers in Immunology|September 7, 2023
Use of Epivolve phage display to generate a monoclonal antibody with opsonic activity directed against a subdominant epitope on extracellular loop 4 of <i>Treponema pallidum</i> BamA (TP0326)Mary R Ferguson, Kristina N Delgado, Shannon McBride, et al.
Journal of Virology|May 6, 2011
An HIV-1 gp120 envelope human monoclonal antibody that recognizes a C1 conformational epitope mediates potent antibody-dependent cellular cytotoxicity (ADCC) activity and defines a common ADCC epitope in human HIV-1 serumGuido Ferrari, Justin Pollara, Daniel Kozink, et al.
Pageof 20

Showing results (61-70 of 200) with videos related to

Sort By:
Pageof 20
The Journal of Infectious Diseases|December 28, 2021
Frequent Development of Broadly Neutralizing Antibodies in Early Life in a Large Cohort of Children With Human Immunodeficiency VirusAmanda Lucier, Youyi Fong, Shuk Hang Li, et al.
Frontiers in Immunology|April 24, 2023
H3N2 influenza hemagglutination inhibition method qualification with data driven statistical methods for human clinical trialsSheetal Sawant, Sarah Anne Gurley, R Glenn Overman, et al.
Journal of Virology|April 13, 2012
A novel variant marking HLA-DP expression levels predicts recovery from hepatitis B virus infectionRasmi Thomas, Chloe L Thio, Richard Apps, et al.
Pediatrics|March 28, 2022
Safety of Live Attenuated Influenza Vaccine in Children With AsthmaAndrew G Sokolow, Amy P Stallings, Carolyn Kercsmar, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 10, 2011
Broadly neutralizing human antibody that recognizes the receptor-binding pocket of influenza virus hemagglutininJames R R Whittle, Ruijun Zhang, Surender Khurana, et al.
Cell Reports|May 11, 2016
A Therapeutic Antibody for Cancer, Derived from Single Human B CellsRyan T Bushey, M Anthony Moody, Nathan L Nicely, et al.
Mbio|July 2, 2020
Recognition Patterns of the C1/C2 Epitopes Involved in Fc-Mediated Response in HIV-1 Natural Infection and the RV114 Vaccine TrialWilliam D Tolbert, Verna Van, Rebekah Sherburn, et al.
Emerging Microbes & Infections|October 29, 2024
Circulating HBsAg-specific B cells are partially rescued in chronically HBV-infected patients with functional cureShuqin Gu, Libo Tang, Ling Guo, et al.
Frontiers in Immunology|September 7, 2023
Use of Epivolve phage display to generate a monoclonal antibody with opsonic activity directed against a subdominant epitope on extracellular loop 4 of <i>Treponema pallidum</i> BamA (TP0326)Mary R Ferguson, Kristina N Delgado, Shannon McBride, et al.
Journal of Virology|May 6, 2011
An HIV-1 gp120 envelope human monoclonal antibody that recognizes a C1 conformational epitope mediates potent antibody-dependent cellular cytotoxicity (ADCC) activity and defines a common ADCC epitope in human HIV-1 serumGuido Ferrari, Justin Pollara, Daniel Kozink, et al.
Pageof 20